马斯克：第三人接受Neuralink的电脑-大脑连接
📖 逐句对照翻译
Businessman Elon Musk said a third person has had a special electronic device directly connected to their brain.
商人埃隆·马斯克表示，已有第三人将特殊电子装置直接植入大脑。
The unidentified person received an implant from Musk’s company Neuralink, which makes devices that link the human brain to computers.
这名身份不明的人士接受了马斯克旗下公司Neuralink的植入物，该公司生产的设备能将人脑与计算机连接起来。
Neuralink is one of many groups working to connect the human nervous system to machines.
Neuralink是众多致力于将人类神经系统与机器连接起来的团队之一。
On the social media service X, which he owns, Musk said: "We've got...three humans with Neuralinks and all are working well."
马斯克在他拥有的社交媒体平台X上表示：“我们已经有……三名植入Neuralink的人类，而且都运行良好。”
Neuralink announced its first brain implant one year ago.
一年前，Neuralink宣布了其首例脑植入手术。
Recently, Musk said the company has improved its devices.
最近，马斯克表示公司已经改进了其设备。
Musk also said Neuralink hopes to implant the experimental devices in 20 to 30 more people this year.
马斯克还表示，Neuralink希望今年能在另外20到30人身上植入这些实验装置。
The second patient reportedly has a spinal cord injury and got the implant last summer.
据报道，第二位患者脊髓受损，于去年夏天接受了植入手术。
The person was playing video games with the help of the device and learning how to use design software.
这个人借助该设备玩电子游戏，并学习如何使用设计软件。
The first patient, also paralyzed after a spinal cord injury, said it helped him play video games and chess.
首位患者也因脊髓损伤而瘫痪，他表示这项技术帮助他玩电子游戏和下棋。
Many other companies and research groups are working on similar projects.
许多其他公司和研究团队也在开展类似的项目。
Two studies published last year in the New England Journal of Medicine describe how brain-computer interfaces, known as BCIs, helped people with Amyotrophic lateral sclerosis (ALS) communicate better.
去年发表在《新英格兰医学杂志》上的两项研究描述了脑机接口（BCI）如何帮助肌萎缩侧索硬化症（ALS）患者更好地沟通。
ALS is a nervous system disease that affects cells in the brain and spinal cord.
ALS是一种影响大脑和脊髓细胞的神经系统疾病。
Others working on brain-computer interface technology
其他从事脑机接口技术研究的人
Nature magazine reported last September that there were published results from 28 trials worldwide of BCIs over the past 25 years.
《自然》杂志去年9月报道称，过去25年间，全球共有28项脑机接口试验的结果得以发表。
Rajesh Rao is co-director of the Center for Neurotechnology at the University of Washington.
拉杰什·拉奥是华盛顿大学神经技术中心的联合主任。
Rao said that many research laboratories have already shown that humans can control computer cursors using BCIs.
拉奥表示，许多研究实验室已经证明，人类可以通过脑机接口控制电脑光标。
Rao said Neuralink might be different from the others in two ways.
拉奥表示，Neuralink可能与其他公司有两个不同之处。
First, the surgery to implant the device is the first to use a robot to implant flexible electrical connectors into a human brain to record brain signals and to control devices.
首先，植入该设备的手术首次使用机器人将柔性电连接器植入人脑，以记录脑信号并控制设备。
Second, those connectors might record from more parts of the brain than interfaces from other research efforts.
其次，这些连接器可能比其它研究工作中的接口记录更多大脑部位的数据。
Rao said other companies such as Synchron, Blackrock Neurotech and Onward Medical are carrying out BCI tests on people using methods that are different from Neuralink.
拉奥表示，Synchron、Blackrock Neurotech和Onward Medical等其他公司正在使用与Neuralink不同的方法对人们进行脑机接口测试。
Benefits of BCIs
脑机接口的好处
Marco Baptista is chief scientific officer of the Christopher & Dana Reeve Foundation.
马可·巴普蒂斯塔是克里斯托弗与达纳·里夫基金会的首席科学官。
He called BCI technology "very exciting" with possible benefits to people with paralysis.
他将BCI技术称为“非常令人兴奋”，并可能为瘫痪者带来益处。
Through clinical tests, "we'll be able to see what's going to be the winning approach," he said.
他说，通过临床试验，“我们就能知道哪种方法会胜出”。
"It's a little early to know."
现在要知道还为时过早。
A clinical trial follows established rules on how to design an experiment involving human subjects.
临床试验遵循关于如何设计涉及人类受试者的实验的既定规则。
How are BCIs tested and supervised?
脑机接口是如何测试和监督的？
Neuralink announced in 2023 that it had received permission from U.S. officials to begin testing its device in people.
Neuralink在2023年宣布，已获得美国官员的许可，开始在人身上测试其设备。
The Food and Drug Administration (FDA) is responsible for approving the sale of medical devices.
美国食品药品监督管理局（FDA）负责批准医疗器械的销售。
Dr. Rita Redberg studies high-risk devices at the University of California, San Francisco.
丽塔·雷德伯格博士在加州大学旧金山分校研究高风险设备。
Redberg said that most medical devices go on the market without clinical trials.
雷德伯格表示，大多数医疗设备未经临床试验就上市了。
However, high-risk devices that are seeking approval from the FDA before they go on the market need what is called an "investigational device exemption."
然而，高风险设备在上市前寻求FDA批准时，需要获得所谓的“研究性设备豁免”。
Neuralink says it has this exemption.
Neuralink表示它拥有这项豁免。
I’m Jill Robbins.
我是吉尔·罗宾斯。
Laura Ungar reported this story for the Associated Press.
劳拉·昂格尔为美联社报道了这一故事。
Jill Robbins adapted it for Learning English.
吉尔·罗宾斯为《学习英语》改编了它。
